EGR1 Regulation of Vasculogenic Mimicry in the MDA-MB-231 Triple-Negative Breast Cancer Cell Line through the Upregulation of KLF4 Expression

被引:3
作者
Jung, Euitaek [1 ]
Lee, Young Han [1 ,2 ]
Ou, Sukjin [1 ]
Kim, Tae Yoon [1 ]
Shin, Soon Young [1 ,2 ]
机构
[1] Konkuk Univ, Dept Biol Sci, Sanghuh Coll Life Sci s, Seoul 05029, South Korea
[2] Konkuk Univ, Canc & Metab Inst, Seoul 05029, South Korea
关键词
Early Growth Response 1; Kruppel-like factor 4; MDA-MB-231; cells; mitogen-activated protein kinase pathway; vasculogenic mimicry; EMT;
D O I
10.3390/ijms241814375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vasculogenic mimicry (VM) is an intriguing phenomenon observed in tumor masses, in which cancer cells organize themselves into capillary-like channels that closely resemble the structure and function of blood vessels. Although VM is believed to contribute to alternative tumor vascularization, the detailed regulatory mechanisms controlling these cellular processes remain poorly understood. Our study aimed to investigate the role of Early Growth Response 1 (EGR1) in regulating VM in aggressive cancer cells, specifically MDA-MB-231 triple-negative breast cancer cells. Our study revealed that EGR1 promotes the formation of capillary-like tubes by MDA-MB-231 cells in a 3-dimensional Matrigel matrix. EGR1 was observed to upregulate Kruppel-like factor 4 (KLF4) expression, which regulates the formation of the capillary-like tube structure. Additionally, our findings highlight the involvement of the ERK1/2 and p38 mitogen-activated protein kinase pathways in mediating the expression of EGR1 and KLF4, underscoring their crucial role in VM in MDA-MB-231 cells. Understanding these regulatory mechanisms will provide valuable insights into potential therapeutic targets for preventing VM during the treatment of triple-negative breast cancer.
引用
收藏
页数:17
相关论文
共 46 条
  • [1] Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers
    Arner, Emily N.
    Du, Wenting
    Brekken, Rolf A.
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [2] Tumor microenvironment complexity and therapeutic implications at a glance
    Baghba, Roghayyeh
    Roshangar, Leila
    Jahanban-Esfahlan, Rana
    Seidi, Khaled
    Ebrahimi-Kalan, Abbas
    Jaymand, Mehdi
    Kolahian, Saeed
    Javaheri, Tahereh
    Zare, Peyman
    [J]. CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
  • [3] The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity
    Chavez-Dominguez, Rodolfo
    Perez-Medina, Mario
    Lopez-Gonzalez, Jose S.
    Galicia-Velasco, Miriam
    Aguilar-Cazares, Dolores
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis
    Chen, Hsiao-Fan
    Huang, Chi-Hung
    Liu, Chung-Ji
    Hung, Jung-Jyh
    Hsu, Chih-Chin
    Teng, Shu-Chun
    Wu, Kou-Juey
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [5] Roles for KRAS in Pancreatic Tumor Development and Progression
    di Magliano, Marina Pasca
    Logsdon, Craig D.
    [J]. GASTROENTEROLOGY, 2013, 144 (06) : 1220 - 1229
  • [6] Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
    Edgar, R
    Domrachev, M
    Lash, AE
    [J]. NUCLEIC ACIDS RESEARCH, 2002, 30 (01) : 207 - 210
  • [7] A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
    El Hallani, Soufiane
    Boisselier, Blandine
    Peglion, Florent
    Rousseau, Audrey
    Colin, Carole
    Idbaih, Ahmed
    Marie, Yannick
    Mokhtari, Karima
    Thomas, Jean-Leon
    Eichmann, Anne
    Delattre, Jean-Yves
    Maniotis, Andrew J.
    Sanson, Marc
    [J]. BRAIN, 2010, 133 : 973 - 982
  • [8] Targeting mutated GTPase KRAS in tumor therapies
    Fan, Guangjin
    Lou, Linlin
    Song, Zhendong
    Zhang, Xiaolei
    Xiong, Xiao-Feng
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 226
  • [9] Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer
    Fatma, Homa
    Siddique, Hifzur Rahman
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) : 853 - 864
  • [10] Forster JC, 2017, HYPOXIA, V5, P21, DOI 10.2147/HP.S133231